Cedar Grove Capital Management, an investment management company, released its first quarter 2025 investor letter. A copy of the letter can be downloaded here. The strategy returned 0.38% in the first quarter compared to -4.27% for the S&P 500 and -9.51% for the Russell 2000. In addition, please check the fund’s top five holdings to know its best picks in 2025. In its first quarter 2025 investor letter, Cedar Grove Capital Management emphasized stocks such as LENSAR, Inc. (NASDAQ:LNSR). LENSAR, Inc. (NASDAQ:LNSR) is a commercial-stage medical device company. The one-month return of LENSAR, Inc. (NASDAQ:LNSR) was -6.64%, and its shares gained 325.94% of their value over the last 52 weeks. On April 9, 2025, LENSAR, Inc. (NASDAQ:LNSR) stock closed at $13.63 per share with a market capitalization of $160.703 million. Cedar Grove Capital Management stated the following regarding LENSAR, Inc. (NASDAQ:LNSR) in its Q1 2025 investor letter: "LENSAR, Inc. (NASDAQ:LNSR) was a recent name that we pitched long near the end of February, calling it deeply undervalued and having many characteristics that were ideal for an outsized return in the coming years. A hand using a laser to perform corneal astigmatism surgery. LENSAR, Inc. (NASDAQ:LNSR) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 5 hedge fund portfolios held LENSAR, Inc. (NASDAQ:LNSR) at the end of the fourth quarter compared to 5 in the third quarter. In 2024, LENSAR, Inc. (NASDAQ:LNSR) experienced notable revenue growth, with fourth-quarter top-line revenue reaching a record of $16.7 million—marking a 38% increase compared to Q4 2023. While we acknowledge the potential of LENSAR, Inc. (NASDAQ:LNSR) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. Story Continues In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: Michael Burry Is Selling These Stocks and A New Dawn Is Coming to US Stocks. Disclosure: None. This article is originally published at Insider Monkey. View Comments
Is LENSAR (LNSR) a Deeply Undervalued Stock?
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...